73 results on '"Diehl, Volker"'
Search Results
2. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)
3. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial
4. Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials
5. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
6. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group
7. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
8. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group
9. The European Cancer Patient’s Bill of Rights, update and implementation 2016
10. Improving perfusion quantification in arterial spin labeling for delayed arrival times by using optimized acquisition schemes
11. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
12. Preface
13. First Hodgkin Cell Line L428 and the CD30 Antigen
14. Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis
15. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
16. Proceedings of the 13th biennial South African Lymphoma Study Group Meeting – Cape Town October 2008
17. Radiotherapy Does Not Influence the Severe Pulmonary Toxicity Observed With the Administration of Gemcitabine and Bleomycin in Patients With Advanced-Stage Hodgkin's Lymphoma Treated With the BAGCOPP Regimen: A Report by the German Hodgkin's Lymphoma Study Group
18. A Contribution to Solve the Problem of the Need for Consolidative Radiotherapy after Intensive Chemotherapy in Advanced Stages of Hodgkin's Lymphoma—Analysis of a Quality Control Program Initiated by the Radiotherapy Reference Center of the German Hodgkin Study Group (GHSG)
19. Preface
20. New Strategies for the Treatment of Advanced-Stage Hodgkin's Lymphoma
21. Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
22. Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysis
23. German Hodgkin's Lymphoma Study Group Trials: Lessons from the Past and Current Strategies
24. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin’s lymphoma—a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group
25. Patterned CpG Methylation of Silenced B Cell Gene Promoters in Classical Hodgkin Lymphoma-derived and Primary Effusion Lymphoma Cell Lines
26. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field—results of a quality assurance program of the German Hodgkin Study Group
27. Initiation of a teleradiotherapeutic network for patients in German lymphoma studies
28. Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy
29. Part I: Hodgkin's lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells
30. Part II: Hodgkin's lymphoma—diagnosis and treatment
31. Thalidomide for systemic capillary leak syndrome
32. Introduction
33. Introduction
34. Challenges in treating hematologic malignancies
35. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial
36. Constitutive Expression of c-FLIP in Hodgkin and Reed-Sternberg Cells
37. Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95
38. Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95
39. Detection of Epstein-Barr Virus in Hodgkin-Reed-Sternberg Cells
40. Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment
41. Can corporatization contribute to quality assurance and cost control in the German hospital sector?
42. Hodgkin’s disease – new treatment strategies toward the cure of patients
43. Body weight changes with protease inhibitor treatment in undernourished HIV-infected patients
44. A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins
45. Building blocks from sugars. Part 23. Hydrophilic 3-pyridinols from fructose and isomaltulose
46. Isolation of single chain antibody fragments with specificity for cell surface antigens by phage display utilizing internal image anti-idiotypic antibodies
47. Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic interaction chromatography
48. Carmustine and the lungs
49. Secondary prophylaxis of Rhodococcus equi pneumonia in HIV infection: breakthrough despite rifampicin/erythromycin suppressive therapy
50. 7b Treatment of intermediate stages
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.